1989 Outstanding Scientific Achievements by a Young Investigator
Timothy James Schroeder will receive the 14th the Association for Diagnostics & Laboratory Medicine (ADLM) Award for Outstanding Scientific Achievements by a Young Investigator. The award is sponsored by Boehringer Mannheim Diagnostics, Inc.
Timothy Schroeder was born in Manhattan, KS. He received his undergraduate degree from Xavier University in Cincinnati, and his graduate studies have been at the University of Cincinnati. He has been a member of the Department of Pathology and Laboratory Medicine at the University of Cincinnati Medical Center since 1981. His research interests have centered around the fields of toxicology and therapeutic drug monitoring, with particular emphasis in the areas of immunopharmacology and diagnostic markers in solid organ transplantation. To this end, he has extensively studied the monitoring of immunosuppressive agents such as cyclosporine and orthoclone OKT3. Additionally, he has been instrumental in developing sensitive and specific tests to differentiate good transplanted organ function from rejection. He has also been a leader at the forefront of utilizing drug metabolism as a diagnostic test and using drug interactions in a beneficial manner to decrease side effects, increase drug efficacy, and decrease drug costs.
Schroeder has published more than 50 papers and a number of book chapters on his research, and has served as a co-editor of the Journal of Clinical Transplantation. He has been a member of the Association for Diagnostics & Laboratory Medicine (formerly AACC) since 1986 and belongs to both the Clinical and Diagnostic Immunology Division and the Therapeutic Drug Monitoring Division of the ADLM. He has participated in three ADLM-sponsored symposia as an invited panelist. Memberships in other societies include the following: American Council on Transplantation, American Transplantation Society, American Society of Transplant Physicians, Association of Medical Laboratory Immunologists, International Society of Heart Transplantation, and International Society of Immunopharmacology. He has received the Young Investigators Award from both the Second International Congress on Cyclosporine and the XII International Congress of the Transplantation Society. Additionally, he has received grants as the principal or co-principal investigator from the following sources: The Kidney Foundation of Greater Cincinnati, Sandoz Pharmaceutical Corp., Abbott Diagnostic Corp., and Ortho Pharmaceutical Corp.
On the local level, Schroeder has been active in the education of medical technologists, physicians, and medical and graduate students at the University of Cincinnati. He has participated with The Kidney Foundation of Greater Cincinnati in teaching patients, improving the general public’s awareness of organ donation, and organizing transplant symposia for professionals in the field.